Androgens and the control of skeletal muscle protein synthesis

Melinda Sheffield-Moore

Research output: Contribution to journalArticle

92 Citations (Scopus)

Abstract

Athletes have long supported the concept that anabolic steroids increase skeletal muscle mass. However, it was only recently that both testosterone and its synthetic analogue, oxandrolone, were proven capable of inducing myotrophic effects in postabsorptive human skeletal muscle. These findings have provided the physiological evidence that anabolic steroids deserve attention in the clinical arena as a pharmacological intervention against losses in lean body mass associated with age, disease, trauma and burn injury. However, we are lacking in vivo molecular evidence that would directly or indirectly link androgens and the androgen receptor with increases in skeletal muscle mass. Clearly, a need exists to link in vivo and in vitro studies from both the physiological and molecular arena as they relate to androgens and the control and regulation of skeletal muscle mass. In this brief review, newly discovered information and emerging theories relating to the direct, indirect, priming and antiglucocorticoid action of androgens on skeletal muscle will be presented.

Original languageEnglish (US)
Pages (from-to)181-186
Number of pages6
JournalAnnals of Medicine
Volume32
Issue number3
StatePublished - Apr 2000

Fingerprint

Muscle Proteins
Androgens
Skeletal Muscle
Testosterone Congeners
Oxandrolone
Information Theory
Wounds and Injuries
Androgen Receptors
Athletes
Testosterone
Pharmacology

Keywords

  • Androgen receptors
  • Androgens
  • Protein synthesis
  • Skeletal muscle mass

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Androgens and the control of skeletal muscle protein synthesis. / Sheffield-Moore, Melinda.

In: Annals of Medicine, Vol. 32, No. 3, 04.2000, p. 181-186.

Research output: Contribution to journalArticle

Sheffield-Moore, M 2000, 'Androgens and the control of skeletal muscle protein synthesis', Annals of Medicine, vol. 32, no. 3, pp. 181-186.
Sheffield-Moore, Melinda. / Androgens and the control of skeletal muscle protein synthesis. In: Annals of Medicine. 2000 ; Vol. 32, No. 3. pp. 181-186.
@article{db26812f2df84f02aa5107084177cdb6,
title = "Androgens and the control of skeletal muscle protein synthesis",
abstract = "Athletes have long supported the concept that anabolic steroids increase skeletal muscle mass. However, it was only recently that both testosterone and its synthetic analogue, oxandrolone, were proven capable of inducing myotrophic effects in postabsorptive human skeletal muscle. These findings have provided the physiological evidence that anabolic steroids deserve attention in the clinical arena as a pharmacological intervention against losses in lean body mass associated with age, disease, trauma and burn injury. However, we are lacking in vivo molecular evidence that would directly or indirectly link androgens and the androgen receptor with increases in skeletal muscle mass. Clearly, a need exists to link in vivo and in vitro studies from both the physiological and molecular arena as they relate to androgens and the control and regulation of skeletal muscle mass. In this brief review, newly discovered information and emerging theories relating to the direct, indirect, priming and antiglucocorticoid action of androgens on skeletal muscle will be presented.",
keywords = "Androgen receptors, Androgens, Protein synthesis, Skeletal muscle mass",
author = "Melinda Sheffield-Moore",
year = "2000",
month = "4",
language = "English (US)",
volume = "32",
pages = "181--186",
journal = "Annals of Medicine",
issn = "0785-3890",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Androgens and the control of skeletal muscle protein synthesis

AU - Sheffield-Moore, Melinda

PY - 2000/4

Y1 - 2000/4

N2 - Athletes have long supported the concept that anabolic steroids increase skeletal muscle mass. However, it was only recently that both testosterone and its synthetic analogue, oxandrolone, were proven capable of inducing myotrophic effects in postabsorptive human skeletal muscle. These findings have provided the physiological evidence that anabolic steroids deserve attention in the clinical arena as a pharmacological intervention against losses in lean body mass associated with age, disease, trauma and burn injury. However, we are lacking in vivo molecular evidence that would directly or indirectly link androgens and the androgen receptor with increases in skeletal muscle mass. Clearly, a need exists to link in vivo and in vitro studies from both the physiological and molecular arena as they relate to androgens and the control and regulation of skeletal muscle mass. In this brief review, newly discovered information and emerging theories relating to the direct, indirect, priming and antiglucocorticoid action of androgens on skeletal muscle will be presented.

AB - Athletes have long supported the concept that anabolic steroids increase skeletal muscle mass. However, it was only recently that both testosterone and its synthetic analogue, oxandrolone, were proven capable of inducing myotrophic effects in postabsorptive human skeletal muscle. These findings have provided the physiological evidence that anabolic steroids deserve attention in the clinical arena as a pharmacological intervention against losses in lean body mass associated with age, disease, trauma and burn injury. However, we are lacking in vivo molecular evidence that would directly or indirectly link androgens and the androgen receptor with increases in skeletal muscle mass. Clearly, a need exists to link in vivo and in vitro studies from both the physiological and molecular arena as they relate to androgens and the control and regulation of skeletal muscle mass. In this brief review, newly discovered information and emerging theories relating to the direct, indirect, priming and antiglucocorticoid action of androgens on skeletal muscle will be presented.

KW - Androgen receptors

KW - Androgens

KW - Protein synthesis

KW - Skeletal muscle mass

UR - http://www.scopus.com/inward/record.url?scp=0034012929&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034012929&partnerID=8YFLogxK

M3 - Article

C2 - 10821325

AN - SCOPUS:0034012929

VL - 32

SP - 181

EP - 186

JO - Annals of Medicine

JF - Annals of Medicine

SN - 0785-3890

IS - 3

ER -